Glomerulonephritis
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Glomerulonephritis Classification and external resources | |
 | |
|---|---|
| Acute Glomerulonephritis: Micro H&E high mag; an excellent example of acute exudative glomerulonephritis. Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology | |
| ICD-10 | N00, N01, N03, N18 |
| ICD-9 | 580-582 |
| DiseasesDB | 5245 |
| MeSH | D005921 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Glomerulonephritis, also known as glomerular nephritis and abbreviated GN', is a primary or secondary immune-mediated renal disease characterized by inflammation of the glomeruli, or small blood vessels in the kidneys. It may present with isolated hematuria and/or proteinuria (blood resp. protein in the urine); or as a nephrotic syndrome, a nephritic syndrome, acute renal failure, or chronic renal failure.
They are categorized into several different pathological patterns, which are broadly grouped into non-proliferative or proliferative types. Diagnosing the pattern of GN is important because the outcome and treatment differs in different types. Primary causes are one which are intrinsic to the kidney, whilst secondary causes are associated with certain infections (bacterial, viral or parasitic pathogens), drugs, systemic disorders (SLE, vasculitis) or cancers.
Non Proliferative
This is characterised by a lack of hypercellularity in the glomeruli. They usually cause nephrotic syndrome. This includes the following types:
Minimal change GN
This form of GN causes 80% of nephrotic syndrome in children, but only 20% in adults. As the name indicates, there are no changes visible on simple light microscopy, but on electron microscopy there is fusion of podocytes (supportive cells in the glomerulus). Immunohistochemistry staining is negative. Treatment consists of supportive care for the massive fluid accumulation in the patients body (= oedema) and as well as steroids to halt the disease process (e.g. Prednisone 1 mg/ kg). Over 90% of children respond well to steroids, being essentially cured after 3 months of treatment. Adults have a lower response rate (80%). Failure to respond to steroids ('steroid resistant') or return of the disease when steroids are stopped ('steroid dependent') may require cytotoxic therapy (e.g. cyclosporin) which is associated with many side-effects. As we all may know
Focal Segmental Glomerulosclerosis (FSGS)
FSGS may be primary or secondary to reflux nephropathy, Alport syndrome, heroin use or HIV. FSGS presents as a nephrotic syndrome with varying degrees of impaired renal function (seen as a rising serum creatinine, hypertension). As the name suggests, only certain foci of glomeruli within the kidney are affected, and then only a segment of an individual glomerulus.
The pathological lesion is sclerosis (fibrosis) within the glomerulus and hyalinisation of the feeding arterioles, but no increase in the number of cells (hence non proliferative). The hyaline is an amorphous material, pink, homogeneous, resulting from combination of plasma proteins, increased mesangial matrix and collagen. Staining for antibodies and complement is essentially negative. Steroids are often tried but not shown to be effective. 50% of people with FSGS continue to have progressive deterioration of kidney function, ending in renal failure.
Membranous glomerulonephritis
Presents as nephrotic syndrome, leading cause in adults (35%). It is usually idiopathic, but may be associated with cancers (lung, bowel), infection (hepatitis, malaria), drugs (penicillamine), SLE. The basement membrane on which the glomerular cells sit is thickened, but no increase in cells. Immune staining shows diffuse granular uptake of IgG (immunoglobulin G) and complement type 3. A third of people continue having the disease, 1/3 remit, 1/3 progress to end-stage kidney failure. As glomerulonephritis progresses (in any type), the tubules of the kidney (which are separate to the glomerulus) also become affected, showing atrophy and hyalinisation. The kidney grossly appears shrunken. Treatment with steroids is attempted if it is progressive.
Proliferative
This type is characterised by increased number of cells in the glomerulus (hypercellular). Usually present as a nephritic syndrome and usually progress to end-stage renal failure (ESRF) over weeks to years (depending on type).
IgA disease (Berger's nephropathy)
This is the most common type of glomerulonephritis in adults world-wide. It usually presents as macroscopic haematuria (visibly bloody urine). It occasionally presents as a nephrotic syndrome. It often affects young males after an upper respiratory tract infection. Microscopic examination of biopsy specimens shows increased number of mesangial cells with increased matrix (the 'cement' which holds everything together). Immuno-staining is positive for immunoglobulin A deposits within the matrix. Prognosis is variable, 20% progress to ESRF. Steroids and immunosuppression are not effective treatments for this disease; ACE inhibitors are the mainstay of treatment.
Post-infectious GN
Post-infectious glomerulonephritis occurs after Streptococcal infection - usually of the skin, after a latency of 10 days. This condition is essentially defined as an inflammation of the kidneys. Light microscopy shows diffuse hypercellularity due to proliferation of endothelial and mesangial cells, inflammatory infiltrate with neutrophils and with monocytes. The Bowman space is reduced (compressed), in severe cases might see cresent formation [see later]. However, biopsy is seldom done because the disease usually regresses. Patients present with a nephritic syndrome. Diagnosis is suggested by positive streptococcal titers in the blood (ASOT). Treatment is supportive, and the disease resolves (as a rule) in 2 weeks.
Mesangiocapillary GN
This is primary, or secondary to SLE, viral hepatitis, hypocomplementemia. One sees 'hypercellular and hyperlobular' glomeruli due to proliferation of both cells and the matrix within the mesangium. Presents usually with as a nephrotic syndrome but can be nephritic, with inevitable progression to ESRF.
Rapidly progressive GN (Crescentic GN)
As the name suggests, this type has a poor prognosis, with rapid progression to kidney failure over weeks. Any of the above types of GN can be rapidly progressive. Additionally two further causes present as solely RPGN.
One is Goodpasture's syndrome. This is an autoimmune disease whereby antibodies are directed against antigens found in the kidney and lungs. As well as kidney failure, patient have hemoptysis (cough up blood). High dose immunosupression is required (intravenous methylprednisone) and cyclophosphamide, plus plasmapharesis.
Immunohistochemistry staining of tissue specimens shows linear IgG deposits.
The second cause is vasculitic disorders such as Wegener's and polyarteritis. There is a lack of immune deposits on staining, but blood tests are positive for ANCA antibody.
Histopathology
The majority of glomeruli present "crescents". Formation of crescents is initiated by passage of fibrin into the Bowman space as a result of increased permeability of glomerular basement membrane. Fibrin stimulates the proliferation of parietal cells of Bowman capsule, and an influx of monocytes. Rapid growing and fibrosis of crescents compresses the capillary loops and decreases the Bowman space which leads to renal failure within weeks or months.
 Glomerulonephritis: Micro H&E med mag; an excellent example of AGN with many neutrophils |
Acute Glomerulonephritis: Micro H&E high mag; an excellent example of acute exudative glomerulonephritis. |
Rapidly progressive glomerulonephritis
Chronic glomerulonephritis
Pathological Findings: A Case Example
Clinical Summary
A 17-year-old white male had end-stage renal disease requiring hemodialysis for 10 years. For the previous four years he had hypertension which slowly increased to about 180/120 mm Hg. Laboratory findings included a greatly elevated BUN and creatinine. He was admitted for bilateral nephrectomy and discharged in satisfactory condition on the 10th postoperative day. He was to be contacted in the future for transplantation.
Autopsy Findings
The left (97 grams) and right (88 grams) kidneys were of similar appearance. Cortices were pale, diffusely granular with a few 1-2 mm cysts. On being sectioned, the cortex of each kidney was thin (4-5 mm) and pale. Renal medullae were pale yellow-tan in color and there was abundant peripelvic fat. The ureters, pelvis, calyces and hilar vessels showed no abnormalities.
 This is a low-power photomicrograph of a saggital section of end stage chronic glomerulonephritis (GN). Note the marked thinning of the cortex (arrow). |
 This is a higher-power photomicrograph of hyalinized glomeruli (arrows) and glomeruli with thick basement membranes. |
 This is a higher-power photomicrograph of hyalinized glomeruli (1) and glomeruli with thickened basement membranes (2). |
 This is a photomicrograph of interstitial and vascular lesions in end stage renal disease. |
 This is an immunofluorescent photomicrograph of granular membranous immunofluorescence (immune complex disease). The antibody used for these studies was specific for IgG. |
 This is an electron micrograph of subepithelial granular electron dense deposits (arrows) which correspond to the granular immunofluorescence seen in the previous image. |
 This is a photomicrograph of a glomerulus from another case with acute poststreptococcal glomerulonephritis. In this case the immune complex glomerular disease is ongoing with necrosis and accumulation of neutrophils in the glomerulus. |
 This immunofluorescent photomicrograph of a glomerulus from a case of acute poststreptococcal glomerulonephritis shows a granular immunofluorescence pattern consistent with immune complex disease. The primary antibody used for this staining was specific for IgG; however antibodies for complement would show a similar pattern. |
 This electron micrograph demonstrates scattered subepithelial dense deposits (arrows) and a polymorphonuclear leukocyte in the lumen. |
 For comparison this is an immunofluorescent photomicrograph of a glomerulus from a patient with Goodpasture's syndrome. The linear (arrows) immunofluorescence is characteristic of Goodpasture's syndrome. |
See also
External links
Images:
E-medicine:
HDCN
HDCN Nephritis Channel - Collection of lectures and links pertaining to glomerulonephritis on the HDCN (Hypertension, Dialysis, and Clinical Nephrology) on-line journal.
Post-infectious glomerulonephritis - mayoclinic.com.
Group A Streptococcal Infections - National Institute of Allergy and Infectious Diseases.
References
WikiDoc Research Resources for Glomerulonephritis | |
|---|---|
| Articles on Glomerulonephritis | Most recent articles on Glomerulonephritis • Most cited articles on Glomerulonephritis • Review articles on Glomerulonephritis • Articles on Glomerulonephritis in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Glomerulonephritis | Powerpoint slides on Glomerulonephritis • Images of Glomerulonephritis • Photos of Glomerulonephritis • Podcasts & MP3s on Glomerulonephritis • Videos on Glomerulonephritis |
| Evidence Based Medicine Regarding Glomerulonephritis | Cochrane Collaboration on Glomerulonephritis • Bandolier on Glomerulonephritis • TRIP on Glomerulonephritis |
| Cost Effectiveness of Glomerulonephritis | Cost Effectiveness of Glomerulonephritis |
| Clinical Trials Involving Glomerulonephritis | Ongoing Trials on Glomerulonephritis at Clinical Trials.gov • Trial results on Glomerulonephritis • Clinical Trials on Glomerulonephritis at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Glomerulonephritis | US National Guidelines Clearinghouse on Glomerulonephritis • NICE Guidance on Glomerulonephritis • NHS PRODIGY Guidance • FDA on Glomerulonephritis • CDC on Glomerulonephritis |
| Textbook Information on Glomerulonephritis | Books and Textbook Information on Glomerulonephritis |
| Pharmacology Resources on Glomerulonephritis | Dosing of Glomerulonephritis • Drug interactions with Glomerulonephritis • Side effects of Glomerulonephritis • Allergic reactions to Glomerulonephritis • Overdose information on Glomerulonephritis • Carcinogenicity information on Glomerulonephritis • Glomerulonephritis in pregnancy • Pharmacokinetics of Glomerulonephritis • |
| Genetics, Pharmacogenomics, and Proteinomics of Glomerulonephritis | Genetics of Glomerulonephritis • Pharmacogenomics of Glomerulonephritis • Proteomics of Glomerulonephritis |
| Newstories on Glomerulonephritis | Glomerulonephritis in the news • Be alerted to news on Glomerulonephritis • News trends on Glomerulonephritis |
| Commentary on Glomerulonephritis | Blogs on Glomerulonephritis |
| Patient Resources on Glomerulonephritis | Patient resources on Glomerulonephritis • Discussion groups on Glomerulonephritis • Patient Handouts on Glomerulonephritis • Directions to Hospitals Treating Glomerulonephritis • Risk calculators and risk factors for Glomerulonephritis |
| Healthcare Provider Resources on Glomerulonephritis | Symptoms of Glomerulonephritis • Causes & Risk Factors for Glomerulonephritis • Diagnostic studies for Glomerulonephritis • Treatment of Glomerulonephritis |
| Continuing Medical Education (CME) Programs on Glomerulonephritis | CME Programs on Glomerulonephritis |
| International Resources on Glomerulonephritis | Glomerulonephritis en Espanol • Glomerulonephritis en Francais |
| Business Resources on Glomerulonephritis | Glomerulonephritis in the Marketplace • Patents on Glomerulonephritis |
| Informatics Resources on Glomerulonephritis | List of terms related to Glomerulonephritis |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
